{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T06:55:46Z","timestamp":1772088946163,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,4,30]],"date-time":"2008-04-30T00:00:00Z","timestamp":1209513600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aesth Plast Surg"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s00266-008-9156-4","type":"journal-article","created":{"date-parts":[[2008,4,29]],"date-time":"2008-04-29T13:39:55Z","timestamp":1209476395000},"page":"743-747","source":"Crossref","is-referenced-by-count":18,"title":["Do Cosmetic Surgeons Consider Estrogen-Containing Drugs to Be of Significant Risk in the Development of Thromboembolism?"],"prefix":"10.1007","volume":"32","author":[{"given":"R. L.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. J.","family":"Hemington-Gorse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. K.","family":"Dhital","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,4,30]]},"reference":[{"key":"9156_CR1","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(96)07113-9","volume":"348","author":"E Daly","year":"1996","unstructured":"Daly E, Vessey MP, Painter R, Hawkins MM (1996) Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 348:977\u2013981","journal-title":"Lancet"},{"key":"9156_CR2","first-page":"1009","volume":"134","author":"BB Gertsman","year":"1991","unstructured":"Gertsman BB (1991) Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease. Am J Epidemiol 134:1009\u20131010","journal-title":"Am J Epidemiol"},{"key":"9156_CR3","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1136\/bmj.291.6494.498","volume":"291","author":"J Guilleband","year":"1985","unstructured":"Guilleband J (1985) Surgery and the pill. BMJ 291:498\u2013499","journal-title":"BMJ"},{"key":"9156_CR4","first-page":"91","volume":"69","author":"SP Helmrich","year":"1987","unstructured":"Helmrich SP, Rosenberg L, Kaufman DW, Strom B, Shapiro S (1987) Venous thromboembolism in relation to oral contraceptive use. Obstet Gynecol 69:91\u201395","journal-title":"Obstet Gynecol"},{"key":"9156_CR5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0008-6363(98)00210-7","volume":"41","author":"M Levi","year":"1999","unstructured":"Levi M, Middeldorp S, Buller HR (1999) Oral contraceptives and hormonal replacement therapy cause an imbalance in coagulation and fibrinolysis which may explain the increased risk of venous thromboembolism. Cardiovasc Res 41:21\u201324","journal-title":"Cardiovasc Res"},{"key":"9156_CR6","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S0002-9378(98)70220-0","volume":"179","author":"MA Lewis","year":"1998","unstructured":"Lewis MA (1998) The epidemiology of oral contraceptive use: a critical review of the studies on the oral contraceptives and the health of young women. Am J Obstet Gynecol 179:1086\u20131098","journal-title":"Am J Obstet Gynecol"},{"key":"9156_CR7","first-page":"1045","volume":"14","author":"EF Mammen","year":"2000","unstructured":"Mammen EF (2000) Combined oral contraceptives and hormonal replacement therapy and thromboembolic disease. Pregnancy Gynecol 14:1045\u20131059","journal-title":"Pregnancy Gynecol"},{"key":"9156_CR8","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/hq0202.102318","volume":"22","author":"FR Rosendaal","year":"2002","unstructured":"Rosendaal FR (2002) Female hormones and thrombosis. Arterioscler Thromb Vasc Biol 22:201\u2013210","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9156_CR9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/074880680001700208","volume":"17","author":"MA Shiffman","year":"2000","unstructured":"Shiffman MA (2000) Guidelines for the prevention of venous thromboembolism. Am J Cosmetic Surg 17:103\u2013105","journal-title":"Am J Cosmetic Surg"},{"key":"9156_CR10","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/00006534-200208000-00073","volume":"110","author":"MA Shiffman","year":"2002","unstructured":"Shiffman MA (2002) Estrogen and thromboembolic problems. Plast Reconstr Surg 110:713\u2013714","journal-title":"Plast Reconstr Surg"},{"key":"9156_CR11","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1089\/154099903770948078","volume":"12","author":"MA Shiffman","year":"2003","unstructured":"Shiffman MA (2003) Estrogen and thromboembolic disorders: should patients stop hormones prior to cosmetic surgery? J Women\u2019s Health 12:853\u2013855","journal-title":"J Women\u2019s Health"},{"key":"9156_CR12","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/bmj.296.6620.447","volume":"296","author":"H Sue-Ling","year":"1988","unstructured":"Sue-Ling H, Hughes LE (1988) Should the pill be stopped preoperatively. BMJ 296:447\u2013448","journal-title":"BMJ"},{"key":"9156_CR13","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2044.1991.tb09646.x","volume":"46","author":"EM Whitehead","year":"1991","unstructured":"Whitehead EM, Whitehead MI (1991) The pill, HRT, and postoperative thromboembolism: cause for concern? Anaesthesia 46:521\u2013522","journal-title":"Anaesthesia"},{"key":"9156_CR14","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/S0140-6736(95)91921-X","volume":"346","author":"N Weiss","year":"1995","unstructured":"Weiss N (1995) Third-generation oral contraceptives: how risky? Lancet 346:1570","journal-title":"Lancet"},{"key":"9156_CR15","doi-asserted-by":"crossref","unstructured":"Thromboembolic Risk Factors Consensus Group (1992) Risk of and prophylaxis for venous thromboembolism in hospital patients. BMJ 305:567\u2013574","DOI":"10.1136\/bmj.305.6853.567"},{"key":"9156_CR16","doi-asserted-by":"crossref","unstructured":"Drugs in the peri-operative period: 1. Stopping or continuing drugs around surgery. DTB 37:62\u201364, 1999","DOI":"10.1136\/dtb.1999.37862"},{"key":"9156_CR17","doi-asserted-by":"crossref","unstructured":"Drugs in the peri-operative period: 3. Hormonal contraceptives and hormone replacement therapy. DTB 37:78\u201380, 1999","DOI":"10.1136\/dtb.1999.371078"},{"key":"9156_CR18","unstructured":"Prophylaxis of venous thromboembolism: Section 10. Oral contraceptives and hormone replacement therapy. Scottish Intercollegiate Guidelines Network, 2003"}],"container-title":["Aesthetic Plastic Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-008-9156-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00266-008-9156-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00266-008-9156-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T13:01:53Z","timestamp":1558702913000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00266-008-9156-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,30]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["9156"],"URL":"https:\/\/doi.org\/10.1007\/s00266-008-9156-4","relation":{},"ISSN":["0364-216X","1432-5241"],"issn-type":[{"value":"0364-216X","type":"print"},{"value":"1432-5241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,30]]}}}